MacroGenics, Inc. (MGNX) Provides Update On Corporate Progress And First Quarter 2014 Financial Results
5/7/2014 9:05:34 AM
ROCKVILLE, Md., May 6, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, today provided a corporate progress update and reported financial results for the quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.